Physician profile
Amine Amine
NPI 1861812828
$2,035.54
in general payments reported to CMS, 2019-2025
18 companies · $874 in 2025
The $874 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $445 · 2022: $474 · 2023: $137 · 2024: $106 · 2025: $874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,116.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $975.28 | 2021-2025 | Trelegy Ellipta, Shingrix |
| Astrazeneca Pharmaceuticals Lp | $217.93 | 2025 | Airsupra |
| Novo Nordisk INC | $139.28 | 2025 | Wegovy, Ozempic, Rybelsus |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $97.58 | 2022-2025 | Lifevest |
| Exact Sciences Corporation | $92.77 | 2025 | Cologuard Collection Kit |
| Edwards Lifesciences Corporation | $83.58 | 2024-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Lilly USA, LLC | $68.86 | 2025 | Mounjaro |
| Inspire Medical Systems, INC. | $64.77 | 2025 | Inspire |
| Corcept Therapeutics | $50.04 | 2025 | Korlym |
| Sanofi-Aventis U.S. LLC | $39.74 | 2025 | |
| Abiomed | $35.95 | 2024-2025 | Impella |
| Amgen INC. | $34.98 | 2025 | Repatha, Otezla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.14 | 2025 | Xifaxan |
| Medtronic, INC. | $27.31 | 2025 | Minimed 780g |
| Alkermes, INC. | $26.02 | 2024 | Aristada, Lybalvi |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $18.70 | 2023 | |
| Baxter Healthcare | $15.85 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Pfizer INC. | $14.76 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amine Amine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.